Publication | Closed Access

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa

Chronic PhasePrognostic FactorsHematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyImmunologyPathologyMyeloid NeoplasiaOncologyInterferon Alfa